Mike Polark
Stock Analyst at Wolfe Research
(3.31)
# 987
Out of 4,876 analysts
74
Total ratings
45.83%
Success rate
4.72%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Initiates: Outperform | $20 | $14.84 | +34.77% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $45.96 | +30.55% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $311.15 | +12.49% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $130.81 | +80.42% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $153.97 | -2.58% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $17.80 | +62.92% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $77.86 | -22.94% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $253.98 | -29.13% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $91.66 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $394.26 | +2.72% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $541.00 | -7.02% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $133.93 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $119.06 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $86.65 | +39.64% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $18.82 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $11.39 | +119.49% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $167.52 | -1.50% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $106.52 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $86.05 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.41 | +24.88% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $7.57 | +177.23% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $238.31 | +4.91% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.31 | +3,183.95% | 1 | Sep 2, 2020 |
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $14.84
Upside: +34.77%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $45.96
Upside: +30.55%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $311.15
Upside: +12.49%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $130.81
Upside: +80.42%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $153.97
Upside: -2.58%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $17.80
Upside: +62.92%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $77.86
Upside: -22.94%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $253.98
Upside: -29.13%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $91.66
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $394.26
Upside: +2.72%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $541.00
Upside: -7.02%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $133.93
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $119.06
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $86.65
Upside: +39.64%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $18.82
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $11.39
Upside: +119.49%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $167.52
Upside: -1.50%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $106.52
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $86.05
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $10.41
Upside: +24.88%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $7.57
Upside: +177.23%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $238.31
Upside: +4.91%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.31
Upside: +3,183.95%